The 1 analyst offering 1 year price forecasts for HRTIS have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to HRTIS in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
HRTIS EPS for the last quarter is −0.14 EUR despite the estimation of −0.12 EUR. In the next quarter EPS is expected to reach −0.12 EUR. Track more of HERANTIS PHARMA OYJ financials and stay on top of what is up with the company.
In the next quarter HERANTIS PHARMA OYJ revenue is expected to reach 5.00 K EUR. Check out HERANTIS PHARMA OYJ revenue and earnings and make informed decisions.
According to analysts, HRTIS price target is 2.20 EUR with a max estimate of 2.20 EUR and a min estimate of 2.20 EUR. Check if this forecast comes true in a year, meanwhile watch HERANTIS PHARMA OYJ stock price chart and keep track of the current situation with HRTIS news and stock market news.